Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

BioPharma Credit Shares Steady as Life Sciences Lender Holds Course

On 2 September 2026, shares in BioPharma Credit (LSE: BPCR) rose 0.21% to $0.98, broadly unchanged in cents terms on the day, giving the fund aMarket Capitalisationof approximately £807.34m. The trust's US dollar-denominated shares reflect its focus on financing transactions with pharmaceutical companies, many …

Divya Sood | 02 September 2026

Polar Capital Global Healthcare Trust Edges Up on Sector Resilience

On 2 September 2026, shares in Polar Capital Global Healthcare Trust (LSE: PCGH) rose 0.11% to 445.00p, up 0.50p on the day, giving the trust aMarket Capitalisationof approximately £477.50m. The move was modest, consistent with a generally stable session for global healthcare equities. As …

Divya Sood | 02 September 2026

Hikma Pharmaceuticals Rises as Generics Maker Gains Ground

Shares in Hikma Pharmaceuticals (LSE:HIK) rose 4.00p to 1,619.00p, a gain of 0.25% on the day, valuing the company at approximately £3,371.27m. The move places Hikma among today's stronger performers among UK-listed pharmaceutical and healthcare stocks, consistent with an improvement in sentiment toward the …

Divya Sood | 02 September 2026

Oxford Nanopore Shares Jump as Sequencing Specialist Attracts Buyers

On 2 September 2026, Oxford Nanopore Technologies (LSE: ONT) shares rose 1.50% to 162.40p, up 2.40p on the day, giving the company aMarket Capitalisationof approximately £1.56bn. The gain came amid a positive session for healthcare and life sciences technology stocks more broadly. As a …

Divya Sood | 02 September 2026

Syncona Shares Rise as Life Sciences Investor Rides Biotech Optimism

On 2 September 2026, Syncona (LSE: SYNC) shares gained 2.29% to close at 116.00p, up 2.60p on the day, giving the company aMarket Capitalisationof approximately £689.70m. The move came amid a broader lift for healthcare and biotechnology-related stocks in London trading that session. As …

Divya Sood | 02 September 2026

LSE:EDEN Shares Gain 4.55%: Eden Research’s Biopesticide Pipeline Comes Into Focus

Eden Research plc has returned to investor attention afterLSE:EDEN gained 4.55% on 2 September 2026, putting the small-cap sustainable crop-protection company back on the radar of investors looking for potentially high-growth biotechnology and agricultural innovation opportunities.

Ankur Sharma | 02 September 2026

Why Is ImmuPharma Stock Up 5.87%? Kapiglucagon and P140 Drive Investor Interest

ImmuPharma plc has become increasingly interesting to investors afterLSE:IMM gained 5.87% on 2 September 2026.

Ankur Sharma | 02 September 2026

LSE:APTA Shares Surge 10.51% as AI, Licensing and Pharma Pipeline Drive Fresh Investor Interest

Aptamer Group plc has become one of the more notable movers among small-cap healthcare stocks, withLSE:APTA rising 10.51%in the latest trading session.

Ankur Sharma | 02 September 2026

Proteome Sciences (LSE:PRM) Surges 13.17% as Chemoproteomics Growth Attracts Investors

Proteome Sciences has become increasingly interesting to investors because the company'sBusinessis undergoing a significant shift.

Ankur Sharma | 02 September 2026

LSE:STX Jumps 7.55%: Full US Control of ACCRUFeR, Profitability and Prescription Growth Drive Investor Interest

Shield Therapeutics has entered September with several important developments converging around its core US business.

Ankur Sharma | 02 September 2026
Support

Hi! How can we help you today?

Loading…